Elyse Katz
Pfizer (United States)(US)
Publications by Year
Research Areas
Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Functional Brain Connectivity Studies, Neuroscience and Neuropharmacology Research, Computational Drug Discovery Methods
Most-Cited Works
- → Anatomical Connectivity of the Subgenual Cingulate Region Targeted with Deep Brain Stimulation for Treatment-Resistant Depression(2007)563 cited
- → Cerebral Glucose Metabolism in Obsessive-Compulsive Hoarding(2004)344 cited
- → A computational neurodegenerative disease progression score: Method and results with the Alzheimer's disease neuroimaging initiative cohort(2012)250 cited
- → Meta-Analysis for Genome-Wide Association Study Identifies Multiple Variants at the BIN1 Locus Associated with Late-Onset Alzheimer's Disease(2011)165 cited
- → Disease progression model for cognitive deterioration from Alzheimer's Disease Neuroimaging Initiative database(2010)138 cited
- → Comparative Effectiveness of Care Coordination Interventions in the Emergency Department: A Systematic Review(2012)119 cited
- → Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed inXenopus laevisoocytes(2007)99 cited
- → De Novo Sirolimus and Reduced-Dose Tacrolimus Versus Standard-Dose Tacrolimus After Liver Transplantation: The 2000–2003 Phase II Prospective Randomized Trial(2014)96 cited
- → Disease progression modeling using Hidden Markov Models(2012)82 cited
- → Genome-wide association study identifies multiple novel loci associated with disease progression in subjects with mild cognitive impairment(2011)44 cited